Advertisement

Ads Placeholder
Loading...

Orchid Pharma Limited

ORCHIDPHAR.BO•BSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹741.55
₹-19.25(-2.53%)
Indian Market opens in 53h 28m

Orchid Pharma Limited (ORCHIDPHAR.BO) Stock Overview

Explore Orchid Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio101.08
EPS (TTM)N/A
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ORCHIDPHAR.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Orchid Pharma Limited (ORCHIDPHAR.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 101.08 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-3.17%
3-Month Change
8.60%
6-Month Change
8.60%
Year-to-Date (YTD) Change
3.53%
1-Year Change
8.60%
3-Year Change
8.60%
5-Year Change
8.60%
All-Time (Max) Change
8.60%

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

CountryIN

Frequently Asked Questions